WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2024 Issue has been successfully launched on NOVEMBER 2024.

Abstract

PHARMACOPHORE-BASED DRUG DESIGN: BRIDGING MOLECULAR INSIGHTS AND THERAPEUTIC INNOVATIONS

Mr. Tushar B. Gajjar*, Mr. Harshil Patel and Mr. Viswam Modi

ABSTRACT

Pharmacophore modelling is a crucial approach in computer-aided drug design (CADD) that facilitates the identification and optimization of new therapeutic agents. This review article synthesizes the fundamental principles, methodologies, and advancements in pharmacophore modelling, highlighting its significance in the drug discovery process. The introduction defines a pharmacophore as the ensemble of steric and electronic features necessary for molecular recognition of a ligand by a biological macromolecule. Ligand-based pharmacophore modelling involves analysing known active compounds to derive a model that captures the essential features required for biological activity. This process includes data setpreparation, feature identification, and virtual screening. Structure-based pharmacophore modelling integrates molecular docking simulations with pharmacophore modelling, considering the spatial arrangement of pharmacophoric features in relation to the target binding site. Pharmacophore modelling has found extensive applications beyond initial screening, such as ADME-Tox predictions, side effect and off-target prediction, and target identification. Recent advancements include the development of user-friendly software tools that simplify the process of pharmacophore generation and analysis. Despite its advantages, pharmacophore modelling is not without limitations. The effectiveness of a pharmacophore model depends on the quality and diversity of the training set, and its application is challenging when no structural information is available for the target or ligands. Future research is expected to focus on integrating pharmacophore modelling with machine learning techniques to enhance predictive accuracy and broaden its applicability in complex biological systems. In conclusion, pharmacophore-based drug design represents a critical intersection of chemistry and computational science, driving innovation in drug discovery. By leveraging the principles of pharmacophore modelling, researchers can efficiently navigate the vast chemical space, identifying promising drug candidates while minimizing the associated costs and time. As computational techniques continue to evolve, the role of pharmacophores in drug design is poised to expand, offering new avenues for therapeutic development.

Keywords: Pharmacophore Modeling, Virtual Screening, Ligand-Based Pharmacophore, Structure-Based Pharmacophore, Computational Drug Design.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More